Trial Details
RECRUITINGBasic Information
| Clinical ID | c689 |
|---|---|
| Identifier | NCT05370885 |
| Trial Title | VE202 in Patients with Mild-to-Moderate Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis|Colitis, Ulcerative |
| Interventions | BIOLOGICAL: VE202|DRUG: Vancomycin Oral Capsule|OTHER: VE202 Placebo|OTHER: Vancomycin Placebo |
Participant Information
| Sponsor | Vedanta Biosciences, Inc. |
|---|---|
| City | Naples |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2023-05-08 |
|---|---|
| Primary Completion Date | 2025-07-31 |
| Completion Date | 2025-11-10 |